Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (window အသစ် ဖွင့်နေပါတယ်)

Arbach O, Funck R, Seibt F, Salama A.

ရင်းမြစ်‎: Transfus Med Hemother 2012;39(3):221-3.

Index လုပ်ထား‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (window အသစ် ဖွင့်နေပါတယ်)

The changing spectrum of drug-induced immune hemolytic anemia. (window အသစ် ဖွင့်နေပါတယ်)

Arndt PA, Garratty G.

ရင်းမြစ်‎: Semin Hematol 2005;42(3):137-44.

Index လုပ်ထား‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (window အသစ် ဖွင့်နေပါတယ်)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (window အသစ် ဖွင့်နေပါတယ်)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

ရင်းမြစ်‎: Blood 2012;119(16):3691-7.

Index လုပ်ထား‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (window အသစ် ဖွင့်နေပါတယ်)

Autoimmune hemolytic anemia. (window အသစ် ဖွင့်နေပါတယ်)

Gehrs BC, Friedberg RC.

ရင်းမြစ်‎: Am J Hematol 2002;69(4):258-71.

Index လုပ်ထား‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (window အသစ် ဖွင့်နေပါတယ်)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (window အသစ် ဖွင့်နေပါတယ်)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

ရင်းမြစ်‎: Blood 2010;116(23):4783-5.

Index လုပ်ထား‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (window အသစ် ဖွင့်နေပါတယ်)

A case of late-onset systemic lupus erythematosus with severe anemia. (window အသစ် ဖွင့်နေပါတယ်)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

ရင်းမြစ်‎: Kurume Med J 2013;60(1):25-8.

Index လုပ်ထား‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (window အသစ် ဖွင့်နေပါတယ်)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (window အသစ် ဖွင့်နေပါတယ်)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

ရင်းမြစ်‎: Blood 2002;100(2):704-6.

Index လုပ်ထား‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (window အသစ် ဖွင့်နေပါတယ်)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (window အသစ် ဖွင့်နေပါတယ်)

Zecca M, De Stefano P, Nobili B, Locatelli F.

ရင်းမြစ်‎: Blood 2001;97(12):3995-7.

Index လုပ်ထား‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (window အသစ် ဖွင့်နေပါတယ်)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (window အသစ် ဖွင့်နေပါတယ်)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

ရင်းမြစ်‎: Blood 2003;101(10):3857-61.

Index လုပ်ထား‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (window အသစ် ဖွင့်နေပါတယ်)